Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PNO Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112961194A discloses novel tridentate PNO ligands enabling high ee and yield in ketone hydrogenation, offering robust supply chain solutions for pharma intermediates.
Patent CN113004341A discloses stable tridentate PNO ligands enabling high-efficiency asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing.
Novel ferrocene-based PNO ligand patent CN113004341B enables high-selectivity asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing and supply chain stability.